Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access

Francesca Fumagalli, Alessandro Aiuti, Laura Lorioli et al.|The Lancet|2022

Cited by 286